Search

everythinglearnresearchcommunity

for

Search:↓

No single biomarker is reliable enough for diagnosing and assessing SLE.

Cyproterone acetate improves skin symptoms and quality of life in women with androgen-related issues.

More than half of patients who had acromegaly surgery experienced hair loss, with varying degrees of recovery.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

People with hair loss conditions experience more anxiety, depression, and a lower quality of life than those without these conditions.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Transplanting hair from the nape and around the ear to the hairline and temples generally satisfies patients and looks natural.

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.

Health workers in non-COVID wards had higher depression and anxiety rates.

Alopecia Areata affects both genders almost equally, mostly on the scalp, with common signs like yellow dots and exclamation mark hairs, especially in young people.

Patients need better information about the risks of long-term steroid use.

Seborrheic dermatitis significantly lowers quality of life, especially in young people, women, and those with higher education.

Pranic meditation significantly improved mental health and quality of life for breast cancer survivors.

Hair transplantation can help transgender patients affirm their gender identity.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Moderate facial angiofibroma significantly reduces quality of life compared to almost-clear cases, highlighting the benefits of treatment.

Nail changes are common in alopecia areata and can indicate its severity.

Alopecia areata patients have lower vitamin D and slightly lower copper levels, so these should be checked.

Low iron levels are strongly linked to chronic hair loss in women.

Androgenetic alopecia with telogen effluvium is the most common hair loss in women with hirsutism.

In 2009, there were new medical devices, treatments for gynecological conditions, updated health guidelines, and legal developments in women's health.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Early detection of chemotherapy side effects allows treatment adjustments, improving patient outcomes.

Individualized treatment improves symptoms and quality of life for women with PCOS.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.